Canagliflozin for Type 2 Diabetes - reduces cardiovascular events.
Canagliflozin reduces major adverse cardiovascular events (MACE) in patients with T2DM. Big paper in the NEJM, (the trials sponsored by...
Graves Hyperthyroidism - information for patients
Dr Philip Kelly, consultant endocrinologist at King's College Hospital discusses Graves' thyrotoxicosis, what is it, how does it pre
